Literature DB >> 12627279

Prevalence and clinical significance of fever in acute exacerbations of chronic obstructive pulmonary disease.

D Lieberman1, O Shmarkov, Y Gelfer, R Varshavsky, D V Lieberman.   

Abstract

Fever is an important, although not always present, sign in acute exacerbation of chronic obstructive pulmonary disease (AECOPD). The objective of this study was to determine the prevalence of fever and its clinical significance in these episodes. Two hundred seventeen AECOPD hospitalizations were included in a prospective study and were categorized as febrile (FH) or afebrile (AFH), using as a cutoff a rectal temperature measurement of 37.8 degrees C during hospitalization. Eighty-six hospitalizations (39.6%) were identified as AFH. The patients in this group had significantly more severe airway obstruction and hypoxemia, a higher rate of chronic obstructive pulmonary disease (COPD) complications, a higher rate of type 3 exacerbation, a shorter length of hospitalization and a higher rate of readmissions than patients in the FH group. The results of this study show that more than one-third of AECOPD hospitalizations are attributable to afebrile episodes. These episodes are characterized by lower rates of bronchitis manifestations in patients with more severe disease. Although the length of hospitalization for these episodes is shorter, the readmission rate is higher.

Entities:  

Mesh:

Year:  2003        PMID: 12627279     DOI: 10.1007/s10096-002-0872-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  3 in total

Review 1.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1995-11       Impact factor: 21.405

2.  Infectious etiologies in acute exacerbation of COPD.

Authors:  D Lieberman; D Lieberman; M Ben-Yaakov; Z Lazarovich; S Hoffman; B Ohana; M G Friedman; B Dvoskin; M Leinonen; I Boldur
Journal:  Diagn Microbiol Infect Dis       Date:  2001-07       Impact factor: 2.803

3.  Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease.

Authors:  N R Anthonisen; J Manfreda; C P Warren; E S Hershfield; G K Harding; N A Nelson
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

  3 in total
  4 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  [Antibiotic prescribing in respiratory tract infections and predictive factors for their use].

Authors:  Carles Llor; Josep María Cots; Lars Bjerrum; Marina Cid; Gloria Guerra; Xavier Arranz; Manuel Gómez; María José Monedero; Juan de Dios Alcántara; Carolina Pérez; Guillermo García; Jesús Ortega; María Luisa Cigüenza; Vicenta Pineda; José Paredes; Juan Luis Burgazzoli; Silvia Hernández
Journal:  Aten Primaria       Date:  2009-08-26       Impact factor: 1.137

Review 3.  [Assessment, triage, and follow-up of a patient with: acute CAP COPD].

Authors:  K Faure
Journal:  Med Mal Infect       Date:  2006-11-07       Impact factor: 2.152

4.  Content Validity of the Comprehensive ICF Core Set for Chronic Obstructive Pulmonary Diseases: An International Delphi Survey.

Authors:  Andrea Jobst; Inge Kirchberger; Alarcos Cieza; Gerold Stucki; Armin Stucki
Journal:  Open Respir Med J       Date:  2013-04-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.